ZA983852B - Therapy for constipation - Google Patents

Therapy for constipation

Info

Publication number
ZA983852B
ZA983852B ZA983852A ZA983852A ZA983852B ZA 983852 B ZA983852 B ZA 983852B ZA 983852 A ZA983852 A ZA 983852A ZA 983852 A ZA983852 A ZA 983852A ZA 983852 B ZA983852 B ZA 983852B
Authority
ZA
South Africa
Prior art keywords
constipation
therapy
Prior art date
Application number
ZA983852A
Other languages
English (en)
Inventor
Thomas Julius Borody
Original Assignee
Borody Thomas J
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Borody Thomas J filed Critical Borody Thomas J
Publication of ZA983852B publication Critical patent/ZA983852B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA983852A 1997-05-07 1998-05-07 Therapy for constipation ZA983852B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPO6653A AUPO665397A0 (en) 1997-05-07 1997-05-07 Novel therapy for constipation

Publications (1)

Publication Number Publication Date
ZA983852B true ZA983852B (en) 1998-11-13

Family

ID=3800945

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA983852A ZA983852B (en) 1997-05-07 1998-05-07 Therapy for constipation

Country Status (13)

Country Link
US (1) US6426338B1 (es)
EP (1) EP0980246B1 (es)
AR (1) AR012671A1 (es)
AT (1) ATE349216T1 (es)
AU (1) AUPO665397A0 (es)
CA (1) CA2289717C (es)
CY (1) CY1107586T1 (es)
DE (1) DE69836735T2 (es)
DK (1) DK0980246T3 (es)
ES (1) ES2279573T3 (es)
PT (1) PT980246E (es)
WO (1) WO1998050043A1 (es)
ZA (1) ZA983852B (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI249519B (en) * 2000-08-29 2006-02-21 Nobex Corp Immunoregulatory compounds and derivatives and methods of treating diseases therewith
US6414016B1 (en) 2000-09-05 2002-07-02 Sucampo, A.G. Anti-constipation composition
US7186855B2 (en) 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US8048924B2 (en) 2001-08-29 2011-11-01 Biocon Limited Methods and compositions employing 4-aminophenylacetic acid compounds
AUPS088702A0 (en) * 2002-03-04 2002-03-28 Borody, Thomas Julius Electrolyte purgative
US7025745B2 (en) * 2002-10-07 2006-04-11 Advanced Cardiovascular Systems, Inc. Method of making a catheter balloon using a tapered mandrel
DE10257824B4 (de) * 2002-12-10 2004-11-11 Kochem, Hans-Günter, Dr. Zusammensetzung zur Schmerzbehandlung, insbesondere zur Behandlung von Gelenkschmerzen
US20050075395A1 (en) * 2003-05-28 2005-04-07 Gary Gordon Continuous dosing regimen
US20040242649A1 (en) * 2003-05-29 2004-12-02 Hagey Anne E. Extended dosing regimen
EP1644008B1 (en) * 2003-05-29 2011-12-21 Abbott Laboratories Continuous dosing regimen with abt-751
AU2005209948B2 (en) 2004-02-06 2009-09-10 Pharmatel (R&D) Pty Limited Use of aminosalicylates in diarrhoea-predominent Irritable Bowel Syndrome
US20050191371A1 (en) * 2004-02-12 2005-09-01 Rizo Andres M. Medical composition
US20080306029A1 (en) * 2004-05-28 2008-12-11 Salix Pharmaceuticals, Inc. Prevention, Treatment, and Amelioration of Radiation Induced Enteritis
EP1773767B1 (en) 2004-07-07 2016-03-09 Biocon Limited Synthesis of azo bonded immunoregulatory compounds
US8921344B2 (en) * 2006-11-03 2014-12-30 Salix Pharmaceuticals, Inc. Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
US7452872B2 (en) * 2005-08-24 2008-11-18 Salix Pharmaceuticals, Inc. Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
CN103948609A (zh) * 2005-08-24 2014-07-30 萨利克斯药品公司 巴柳氮制剂及其生产和应用
NZ598716A (en) * 2009-10-26 2014-08-29 Borody Thomas J Novel enteric combination therapy
PL3564357T3 (pl) 2010-02-01 2022-08-08 Rebiotix, Inc. Bakterioterapia zapalenia jelita grubego z clostridium difficile
JP2013525440A (ja) 2010-04-26 2013-06-20 サリックス ファーマシューティカルズ リミテッド 男性の治療のための２−ヒドロキシ−５−フェニルアゾ安息香酸誘導体の製剤および使用
CN103338768B (zh) 2010-12-13 2019-04-19 萨利克斯药品有限公司 胃和结肠的配制剂及其制备和使用方法
JP2015514715A (ja) * 2012-03-30 2015-05-21 タケダ ファーマシューティカルズ ユー．エス．エー． インコーポレイティド コルヒチン製剤、その製造方法および使用方法
TR201904884T4 (tr) 2012-07-27 2019-05-21 Redhill Biopharma Ltd Koloni̇k boşaltmada kullanima yöneli̇k formülasyonlar ve formülasyonlarin üreti̇m yöntemleri̇
US9782445B2 (en) 2013-06-05 2017-10-10 Rebiotix, Inc. Microbiota restoration therapy (MRT), compositions and methods of manufacture
US10383901B2 (en) 2013-06-05 2019-08-20 Rebiotix, Inc. Microbiota restoration therapy (MRT), compositions and methods of manufacture
EP4234011A3 (en) 2013-06-05 2023-09-20 Rebiotix, Inc. Microbiota restoration therapy (mrt), compositions and methods of manufacture
US9694039B2 (en) 2013-06-05 2017-07-04 Rebiotix, Inc. Microbiota restoration therapy (MRT), compositions and methods of manufacture
US9511099B2 (en) 2013-06-05 2016-12-06 Rebiotix, Inc. Microbiota restoration therapy (MRT), compositions and methods of manufacture
US9511100B2 (en) 2013-06-05 2016-12-06 Rebiotix, Inc. Microbiota restoration therapy (MRT), compositions and methods of manufacture
US10905726B2 (en) 2015-06-09 2021-02-02 Rebiotix, Inc. Microbiota restoration therapy (MRT) compositions and methods of manufacture
US10828340B2 (en) 2015-06-09 2020-11-10 Rebiotix, Inc. Microbiota restoration therapy (MRT) compositions and methods of manufacture
CA2986915C (en) 2015-06-09 2023-09-19 Rebiotix, Inc. Microbiota restoration therapy (mrt) compositions and methods of manufacture
US10799539B2 (en) 2015-06-09 2020-10-13 Rebiotix, Inc. Microbiota restoration therapy (MRT) compositions and methods of manufacture

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69133348T3 (de) * 1990-10-22 2011-05-12 Centre for Digestive Diseases Pty, Ltd. Behandlung von nicht-entzündlichen darmerkrankungen
US5519014A (en) * 1990-10-22 1996-05-21 Borody; Thomas J. Treatment of non-inflammatory and non-infectious bowel disorders

Also Published As

Publication number Publication date
CA2289717A1 (en) 1998-11-12
AUPO665397A0 (en) 1997-05-29
DE69836735T2 (de) 2007-10-11
US6426338B1 (en) 2002-07-30
ES2279573T3 (es) 2007-08-16
EP0980246A4 (en) 2004-04-14
DK0980246T3 (da) 2007-05-07
ATE349216T1 (de) 2007-01-15
WO1998050043A1 (en) 1998-11-12
DE69836735D1 (de) 2007-02-08
EP0980246A1 (en) 2000-02-23
CA2289717C (en) 2009-02-03
EP0980246B1 (en) 2006-12-27
AR012671A1 (es) 2000-11-08
PT980246E (pt) 2007-02-28
CY1107586T1 (el) 2013-03-13

Similar Documents

Publication Publication Date Title
ZA983852B (en) Therapy for constipation
EG24678A (en) Combination therapy
ZA983176B (en) Therapeutic compounds
GB9725782D0 (en) Therapeutic agents
GB9708484D0 (en) Therapeutic agents
GB9708945D0 (en) Therapeutic agents
GB9704948D0 (en) Therapeutic agents
GB9702524D0 (en) Therapeutic agents
IL127306A0 (en) Combination therapy
GB9715977D0 (en) Therapeutic agents
GB9711114D0 (en) Therapeutic agents
HUP0300615A3 (en) Therapeutic agents
GB9700939D0 (en) Therapy
GB9702392D0 (en) Therapeutic agents
GB9700555D0 (en) Therapeutic agents
GB9716345D0 (en) Therapeutic compounds
GB9716347D0 (en) Therapeutic compounds
GB9716344D0 (en) Therapeutic compounds
GB9716463D0 (en) Therapeutic agents
GB9708698D0 (en) Materials for therapy
GB9716457D0 (en) Therapeutic agents
GB9704885D0 (en) Therapy
GB9705401D0 (en) Therapeutic compounds
GB9716111D0 (en) Therapeutic compounds
GB9710743D0 (en) Therapeutic agents